Literature DB >> 30684584

Construction of artificial micro-aerobic metabolism for energy- and carbon-efficient synthesis of medium chain fatty acids in Escherichia coli.

Junjun Wu1, Zhe Wang2, Xuguo Duan3, Peng Zhou2, Pingcheng Liu2, Zhen Pang2, Yu Wang2, Xuejun Wang2, Wei Li2, Mingsheng Dong4.   

Abstract

Medium-chain (C6-C10) chemicals are important components of fuels, commodities and fine chemicals. Numerous exciting achievements have proven reversed β-oxidation cycle as a promising platform to synthesize these chemicals. However, under native central carbon metabolism, energetic and redox constraints limit the efficient operation of reversed β-oxidation cycle. Current fermentative platform has to use different chemically and energetically inefficient ways for acetyl-CoA and NADH biosynthesis, respectively. The characteristics such as supplementation of additional acetate and formate or high ATP requirement makes this platform incompatible with large-scale production. Here, an artificial micro-aerobic metabolism for energy and carbon-efficient conversion of glycerol to MCFAs was constructed to present solutions towards these barriers. After evaluating numerous bacteria pathways under micro-aerobic conditions, one synthetic metabolic step enabling biosynthesis of acetyl-CoA and NADH simultaneously, without any energy cost and additional carbon requirement, and reducing loss of carbon to carbon dioxide-emitting reactions, was conceived and successfully constructed. The pyruvate dehydrogenase from Enterococcus faecalis was identified and biochemically characterized, demonstrating the most suitable characteristics. Furthermore, the carbon and energy metabolism in Escherichia coli was rewired by the clustered regularly interspaced short palindromic repeats interference system, inhibiting native fermentation pathways outcompeting this synthetic step. The present engineered strain exhibited a 15.7-fold increase in MCFA titer compared with that of the initial strain, and produced 15.67 g/L MCFAs from the biodiesel byproduct glycerol in 3-L bioreactor without exogenous feed of acetate or formate, representing the highest MCFA titer reported to date. This work demonstrates this artificial micro-aerobic metabolism has the potential to enable the cost-effective, large-scale production of fatty acids and other value-added reduced chemicals.
Copyright © 2019 International Metabolic Engineering Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ATP; Metabolic engineering; NADH; Synthetic biology; β-oxidation reversal

Mesh:

Substances:

Year:  2019        PMID: 30684584     DOI: 10.1016/j.ymben.2019.01.006

Source DB:  PubMed          Journal:  Metab Eng        ISSN: 1096-7176            Impact factor:   9.783


  4 in total

1.  Cell-free prototyping enables implementation of optimized reverse β-oxidation pathways in heterotrophic and autotrophic bacteria.

Authors:  Bastian Vögeli; Luca Schulz; Shivani Garg; Katia Tarasava; James M Clomburg; Seung Hwan Lee; Aislinn Gonnot; Elamar Hakim Moully; Blaise R Kimmel; Loan Tran; Hunter Zeleznik; Steven D Brown; Sean D Simpson; Milan Mrksich; Ashty S Karim; Ramon Gonzalez; Michael Köpke; Michael C Jewett
Journal:  Nat Commun       Date:  2022-06-01       Impact factor: 17.694

2.  Expressing a cytosolic pyruvate dehydrogenase complex to increase free fatty acid production in Saccharomyces cerevisiae.

Authors:  Yiming Zhang; Mo Su; Ning Qin; Jens Nielsen; Zihe Liu
Journal:  Microb Cell Fact       Date:  2020-12-10       Impact factor: 5.328

3.  Reverse β-oxidation pathways for efficient chemical production.

Authors:  Katia Tarasava; Seung Hwan Lee; Jing Chen; Michael Köpke; Michael C Jewett; Ramon Gonzalez
Journal:  J Ind Microbiol Biotechnol       Date:  2022-04-14       Impact factor: 4.258

4.  Metabolic engineering strategies to produce medium-chain oleochemicals via acyl-ACP:CoA transacylase activity.

Authors:  Qiang Yan; William T Cordell; Michael A Jindra; Dylan K Courtney; Madeline K Kuckuk; Xuanqi Chen; Brian F Pfleger
Journal:  Nat Commun       Date:  2022-03-25       Impact factor: 17.694

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.